Immune tolerance in the tumor microenvironment is closely involved in tumor progression caused by T-cell regulation via inhibitory signals of immune suppressive cytokine (IL-10), immune checkpoint molecules (programmed death-1 ligand 1 (PD-L1)), transforming growth factor-β, and prostaglandin E213. The gene discussed is IL10; the disease is neoplasm.